Histone deacetylase 9 as a negative regulator for choline acetyltransferase gene in NG108-15 neuronal cells

Neuroscience

Volumn 205, Issue , 2012, Pages 63-72

  Aizawa, S ^a   Teramoto, K ^a   Yamamuro, Y ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Choline acetyltransferase; Cholinergic neuron; Histone deacetylase 9; Histone deacetylase inhibitor; NG108 15 cells

Indexed keywords

HISTONE DEACETYLASE; HISTONE DEACETYLASE 9; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CHOLINE ACETYLTRANSFERASE GENE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE LOCATION; GENE SILENCING; IMMUNOFLUORESCENCE MICROSCOPY; NERVE CELL; NERVE CELL DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; REGULATOR GENE; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

ACETYLCHOLINE; ANIMALS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CHOLINE O-ACETYLTRANSFERASE; CHOLINERGIC NEURONS; DOWN-REGULATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HISTONE DEACETYLASES; HYBRIDOMAS; MICE; NEUROGENESIS; RATS; REPRESSOR PROTEINS;

EID: 84858009067     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.12.024     Document Type: Article

References (64)

1. Abel T., Zukin R.S. Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders. Curr Opin Pharmacol 2008, 8:57-64.
2. Aizawa S., Yamamuro Y. Involvement of histone acetylation in the regulation of choline acetyltransferase gene in NG108-15 neuronal cells. Neurochem Int 2010, 56:627-633.
3. Ashraf S.I., Ip Y.T. Transcriptional control: repression by local chromatin modification. Curr Biol 1998, 8:R683-R686.
4. Balasubramaniyan V., Boddeke E., Bakels R., Küst B., Kooistra S., Veneman A., Copray S. Effects of histone deacetylation inhibition on neuronal differentiation of embryonic mouse neural stem cells. Neuroscience 2006, 143:939-951.
5. Bolden J.E., Peart M.J., Johnstone R.W. Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov 2006, 5:769-784.
6. Burtrup J.T., Newberry N.R. Electrophysiological consequences of ligand binding to the desensitized 5-HT3 receptor in mammalian NG108-15 cells. J Physiol 1996, 490:679-690.
7. Cairns B.R. The logic of chromatin architecture and remodeling at promoters. Nature 2009, 461:193-198.
8. Carew J.S., Giles F.J., Nawrocki S.T. Histone deacetylase inhibitors: mechanisms of cell death and promise in combination cancer therapy. Cancer Lett 2008, 269:7-17.
9. Christian C.N., Nelson P.G., Bullock P., Mullinax D., Nirenberg M. Pharmacologic responses of cells of a neuroblastoma X glioma hybrid clone and modulation of synapses between hybrid cells and mouse myotubes. Brain Res 1978, 147:261-276.
10. Chrivia J.C., Kwok R.P., Lamb N., Hagiwara M., Montminy M.R., Goodman R.H. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 1993, 365:855-859.
11. Dressel U., Bailey P.J., Wang S.C., Downes M., Evans R.M., Muscat G.E. A dynamic role for HDAC7 in MEF2-mediated muscle differentiation. J Biol Chem 2001, 276:17007-17013.
12. Fukuda K., Higashida H., Kudo T., Maeda A., Makiba I., Bujo H., Mishina M., Numa S. Selective coupling with K+ currents of muscarinic acetylcholine receptor subtypes in NG108-15 cells. Nature 1988, 335:355-358.
13. Gao L., Cueto M.A., Asselbergs F., Atadja P. Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family. J Biol Chem 2002, 277:25748-25755.
14. Gonzalez G.A., Montminy M.R. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 1989, 59:675-680.
15. Göttlicher M., Minucci S., Zhu P., Krämer O.H., Schimpf A., Giavara S., Sleeman J.P., Lo Coco F., Nervi C., Pelicci P.G., Heinzel T. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J 2001, 20:6969-6978.
16. Haigis M.C., Guarente L.P. Mammalian sirtuins-emerging roles in physiology, aging, and calorie restriction. Genes Dev 2006, 20:2913-2921.
17. Hsieh J., Gage F.H. Chromatin remodeling in neural development and plasticity. Curr Opin Genet Dev 2005, 17:664-671.
18. Hsieh J., Nakashima K., Kuwabara T., Mejia E., Gage F.H. Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells. Proc Natl Acad Sci U S A 2004, 101:16659-16664.
19. Jenuwein T., Allis C.D. Translating the histone code. Science 2001, 293:1074-1080.
20. Johnson D., Horsley S.W., Moloney D.M., Oldridge M., Twigg S.R., Walsh S., Barrow M., Njølstad P.R., Kunz J., Ashworth G.J., Wall S.A., Kearney L., Wilkie A.O. A comprehensive screen for TWIST mutations in patients with craniosynostosis identifies a new microdeletion syndrome of chromosome band 7p211. Am J Hum Genet 1998, 63:1282-1293.
21. Kao H.Y., Verdel A., Tsai C.C., Simon C., Juguilon H., Khochbin S. Mechanism for nucleocytoplasmic shuttling of histone deacetylase 7. J Biol Chem 2001, 276:47496-47507.
22. Kasai H., Neher E. Dihydropyridine-sensitive and omega-conotoxin-sensitive calcium channels in a mammalian neuroblastoma-glioma cell line. J Physiol 1992, 448:161-188.
23. Kawaguchi A., Asano H., Matsushima K., Wada T., Yoshida S., Ichida S. Enhancement of sodium current in NG108-15 cells during neural differentiation is mainly due to an increase in NaV17 expression. Neurochem Res 2007, 32:1469-1475.
24. Khorasanizadeh S. The nucleosome: from genomic organization to genomic regulation. Cell 2004, 116:259-272.
25. Kouzarides T. Chromatin modifications and their function. Cell 2007, 128:693-705.
26. Leifer D., Li Y.L., Wehr K. Myocyte-specific enhancer binding factor 2C expression in fetal mouse brain development. J Mol Neurosci 1997, 8:131-143.
27. Lemercier C., Verdel A., Galloo B., Curtet S., Brocard M.P., Khochbin S. mHDA1/HDAC5 histone deacetylase interacts with and represses MEF2A transcriptional activity. J Biol Chem 2000, 275:15594-15599.
28. Lewanda A.F., Green E.D., Weissenbach J., Jerald H., Taylor E., Summar M.L., Phillips J.A., Cohen M., Feingold M., Mouradian W., Clarren S.K., Jabs E.W. Evidence that the Saethre-Chotzen syndrome locus lies between D7S664 and D7S507, by genetic analysis and detection of a microdeletion in a patient. Am J Hum Genet 1994, 55:1195-1201.
29. Lonze B.E., Ginty D.D. Function and regulation of CREB family transcription factors in the nervous system. Neuron 2002, 35:605-623.
30. Lu J., McKinsey T.A., Nicol R.L., Olson E.N. Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases. Proc Natl Acad Sci U S A 2000, 97:4070-4075.
31. MacDermot J., Higashida H., Wilson S.P., Matsuzawa H., Minna J., Nirenberg M. Adenylate cyclase and acetylcholine release regulated by separate serotonin receptors of somatic cell hybrids. Proc Natl Acad Sci U S A 1979, 76:1135-1139.
32. Mai A., Massa S., Pezzi R., Simeoni S., Rotili D., Nebbioso A., Scognamiglio A., Altucci L., Loidl P., Brosch G. Class II (IIa)-selective histone deacetylase inhibitors1. Synthesis and biological evaluation of novel (aryloxopropenyl)pyrrolyl hydroxyamides. J Med Chem 2005, 48:3344-3353.
33. Mao Z., Bonni A., Xia F., Nadal-Vicens M., Greenberg M.E. Neuronal activity-dependent cell survival mediated by transcription factor MEF2. Science 1999, 286:785-790.
34. Mao Z., Wiedmann M. Calcineurin enhances MEF2 DNA binding activity in calcium-dependent survival of cerebellar granule neurons. J Biol Chem 1999, 274:31102-31107.
35. McKinsey T.A., Zhang C.L., Lu J., Olson E.N. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 2000, 408:106-111.
36. McKinsey T.A., Zhang C.L., Olson E.N. Control of muscle development by dueling HATs and HDACs. Curr Opin Genet Dev 2001, 11:497-504.
37. Michishita E., Park J.Y., Burneskis J.M., Barrett J.C., Horikawa I. Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol Biol Cell 2005, 16:4623-4635.
38. Misawa H., Ishii K., Deguchi T. Gene expression of mouse choline acetyltransferase. Alternative splicing and identification of a highly active promoter region. J Biol Chem 1992, 267:20392-20399.
39. Misawa H., Takahashi R., Deguchi T. Transcriptional regulation of choline acetyltransferase gene by cyclic AMP. J Neurochem 1993, 60:1383-1387.
40. Montminy M.R., Sevarino K.A., Wagner J.A., Mandel G., Goodman R.H. Identification of a cyclic-AMP-responsive element within the rat somatostatin gene. Proc Natl Acad Sci U S A 1986, 83:6682-6686.
41. Morrison B.E., D'Mello S.R. Polydactyly in mice lacking HDAC9/HDRP. Exp Biol Med (Maywood) 2008, 233:980-988.
42. Myers P.R., Livengood D.R. Dopamine depolarizing response in a vertebrate neuronal somatic cell hybrid. Nature 1975, 255:235-237.
43. Nelson P., Christian C., Nirenberg M. Synapse formation between clonal neuroblastoma×glioma hybrid cells and striated muscle cells. Proc Natl Acad Sci U S A 1976, 73:123-127.
44. Nelson P.G., Christian C.N., Daniels M.P., Henkart M., Bullock P., Mullinax D., Nirenberg M. Formation of synapses between cells of a neuroblastoma×glioma hybrid clone and mouse myotubes. Brain Res 1978, 147:245-259.
45. Nirenberg M., Wilson S., Higashida H., Rotter A., Kruger K., Busis N., Ray R., Kenimer J.G., Alder M. Modulation of synapse formation by cyclic adenosine monophosphate. Science 1983, 222:794-799.
46. Ogryzko V.V., Schiltz R.L., Russanova V., Howard B.H., Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 1996, 87:953-959.
47. Okamoto S., Krainc D., Sherman K., Lipton S.A. Antiapoptotic role of the p38 mitogen-activated protein kinase-myocyte enhancer factor 2 transcription factor pathway during neuronal differentiation. Proc Natl Acad Sci U S A 2000, 97:7561-7566.
48. Petrie K., Guidez F., Howell L., Healy L., Waxman S., Greaves M., Zelent A. The histone deacetylase 9 gene encodes multiple protein isoforms. J Biol Chem 2003, 278:16059-16072.
49. Phiel C.J., Zhang F., Huang E.Y., Guenther M.G., Lazar M.A., Klein P.S. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 2001, 276:36734-36741.
50. Pu H., Zhai P., Gurney M. Enhancer, silencer, and growth factor responsive regulatory sequences in the promoter for the mouse choline acetyltransferase gene. Mol Cell Neurosci 1993, 4:131-142.
51. Quirin-Stricker C., Mauvais C., Schmitt M. Transcriptional activation of human choline acetyltransferase by AP2- and NGF-induced factors. Brain Res Mol Brain Res 1997, 49:165-174.
52. Shimojo M., Wu D., Hersh L.B. The cholinergic gene locus is coordinately regulated by protein kinase A II in PC12 cells. J Neurochem 1998, 71:1118-1126.
53. Sparrow D.B., Miska E.A., Langley E., Reynaud-Deonauth S., Kotecha S., Towers N., Spohr G., Kouzarides T., Mohun T.J. MEF-2 function is modified by a novel co-repressor, MITR. EMBO J 1999, 18:5085-5098.
54. Stankiewicz P., Thiele H., Baldermann C., Krüger A., Giannakudis I., Dörr S., Werner N., Kunz J., Rappold G.A., Hansmann I. Phenotypic findings due to trisomy 7p15.3-pter including the TWIST locus. Am J Med Genet 2001, 103:56-62.
55. Sugo N., Oshiro H., Takemura M., Kobayashi T., Kohno Y., Uesaka N., Song W.J., Yamamoto N. Nucleocytoplasmic translocation of HDAC9 regulates gene expression and dendritic growth in developing cortical neurons. Eur J Neurosci 2010, 31:1521-1532.
56. Tsuji K., Narahara K., Kikkawa K., Murakami M., Yokoyama Y., Ninomiya S., Seino Y. Craniosynostosis and hemizygosity for D7S135 caused by a de novo and apparently balanced t(6;7) translocation. Am J Med Genet 1994, 49:98-102.
57. Verdin E., Dequiedt F., Kasler H.G. Class II histone deacetylases: versatile regulators. Trends Genet 2003, 19:286-293.
58. Wade P.A. Transcriptional control at regulatory checkpoints by histone deacetylases: molecular connections between cancer and chromatin. Hum Mol Genet 2001, 10:693-698.
59. Wang A.H., Bertos N.R., Vezmar M., Pelletier N., Crosato M., Heng H.H., Th'ng J., Han J., Yang X.J. HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor. Mol Cell Biol 1999, 19:7816-7827.
60. Yamamoto K.K., Gonzalez G.A., Biggs W.H., Montminy M.R. Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB. Nature 1988, 334:494-498.
61. Yang X.J., Seto E. The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men. Nat Rev Mol Cell Biol 2008, 9:206-218.
62. Yoshida M., Kijima M., Akita M., Beppu T. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J Biol Chem 1990, 265:17174-17179.
63. Zhang C.L., McKinsey T.A., Chang S., Antos C.L., Hill J.A., Olson E.N. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 2002, 110:479-488.
64. Zhou X., Marks P.A., Rifkind R.A., Richon V.M. Cloning and characterization of a histone deacetylase, HDAC9. Proc Natl Acad Sci U S A 2001, 98:10572-10577.